AIDX · 20/20 Biolabs, Inc.

$0.49 -0.02 (-4.10%) At close · Jul 24

Market Cap

$5.21M

10.61M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Cohen	CEO	$250,000	—	—	—	—	$75,499	$325,499
Jiming Zhou	COO	$220,000	—	—	—	—	$5,647	$225,647
Michael Lebowitz	Chief Scientific Officer	$89,600	—	—	$62,000	—	—	$151,600

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Cohen	CEO	$250,000	—	—	$483,883	—	$62,374	$796,257
Jiming Zhou	COO	$220,000	—	—	$440,496	—	$6,673	$667,169
Michael Lebowitz	Chief Scientific Officer	$76,800	—	—	$193,553	—	—	$270,353

Key facts CIK 1139685 CUSIP 90138K101 13F (30d) 2 filings 2 filers Visit website Investor relations